Group 1 - Stonegate Capital Partners has initiated coverage on Seabridge Gold Inc. (NYSE: SA) as of September 15, 2025 [1] - As of Q2 2025, Seabridge Gold reported cash and cash equivalents of $121.4 million, bolstered by a $100.2 million equity financing in February 2025 and a $30.5 million flow-through financing in June 2025 [1] - The company is focused on advancing its flagship KSM project and exploration at Iskut, 3 Aces, and Snowstorm [1] Group 2 - Seabridge Gold renewed its $750 million base shelf prospectus and $100 million ATM facility in early 2025 [1] - The company reported a Q2 net profit of $12.3 million ($0.12/share), a decrease from $45.2 million in Q2 2024, primarily due to the remeasurement of secured note liabilities [8] - Seabridge invested $21.1 million into projects during the quarter, and drilling at Iskut's Snip North confirmed a large copper-gold porphyry deposit, with a maiden resource estimate expected in early 2026 [8]

Swansea City AFC, the second tier football team, is seeking to raise £50 million in equity to accelerate the Welsh club’s growth https://t.co/HqfQ3uTpOM ...

Core Points - Dryden Gold Corp. has successfully closed its upsized non-brokered equity financing, raising a total of $7,820,120 through the issuance of 31,721,667 common shares [1][2] - Centerra Gold Inc. exercised its 'top-up right' to maintain a 9.9% interest in Dryden Gold, as per the investor rights agreements [2] - The proceeds from the financing will be allocated to drilling and regional field work on the Dryden Gold Property, qualifying as eligible resource exploration expenses under Canadian tax laws [3] Financing Details - The financing consisted of three types of shares: 9,216,667 flow-through common shares (FT Shares) at $0.24 each, 13,180,000 charity flow-through common shares (CFT Shares) at $0.284 each, and 9,325,000 hard dollar common shares (HD Shares) at $0.20 each [1] - The total proceeds from FT Shares were approximately $2,212,000, from CFT Shares were about $3,743,120, and from HD Shares were around $1,865,000 [1] Use of Proceeds - Gross proceeds from FT Shares and CFT Shares will fund additional drilling and field work on the Dryden Gold Property, qualifying as Canadian exploration expenses and flow-through mining expenditures [3] - Proceeds from HD Shares will be used for working capital, general and administrative expenses, and marketing [3] Insider Participation - The CEO of Dryden Gold subscribed for 250,000 HD Shares, while the VP of Exploration subscribed for $50,000 worth of HD Shares [4] - The issuance of HD Shares to insiders is classified as a related party transaction, with the company relying on exemptions from formal valuation and minority shareholder approval requirements [4] Regulatory Compliance - The share issuance is subject to final acceptance by the TSX Venture Exchange and compliance with applicable regulatory requirements [5] - The financing was conducted under the Listed Issuer Financing Exemption, meaning it will not be subject to a hold period under Canadian securities laws [5]

Core Insights - TMX Group reported a significant decrease in financing activity on the Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) for July 2025, with total financings raised down 68% from the previous month but up 255% compared to July 2024 [2][4]. TSX Summary - In July 2025, TSX welcomed 12 new issuers, a decrease from 25 in June 2025 and an increase from 10 in July 2024 [2][5]. - Total financings raised amounted to $1.22 billion, a sharp decline from $3.77 billion in June 2025 but a significant increase from $343.36 million in July 2024 [5]. - The total number of financings was 27, down from 55 in the previous month and up from 17 in July 2024 [2][5]. - Year-to-date statistics show 152 new issuers listed, a 76.7% increase from 86 in 2024, and total financings raised of $9.71 billion, down 8% from $10.56 billion in 2024 [6]. TSXV Summary - TSXV had one new issuer in July 2025, down from five in June 2025 and three in July 2024 [4][7]. - Total financings raised were $705.31 million, a slight decrease of 3% from the previous month but up 49% from July 2024 [4][8]. - The total number of financings was 139, compared to 100 in June 2025 and 93 in July 2024 [4][8]. - Year-to-date statistics indicate 23 new issuers listed, a decrease of 20.7% from 29 in 2024, with total financings raised of $4.02 billion, a 63% increase from $2.46 billion in 2024 [9]. Market Capitalization - The market capitalization of listed issues on TSX was approximately $5.56 trillion in July 2025, reflecting growth from $4.63 trillion in July 2024 [5][6]. - TSXV's market capitalization was around $112.08 billion, up 42.2% from $78.83 billion in July 2024 [9].

Core Viewpoint - Assembly Biosciences, Inc. has announced a registered offering of common stock and warrants, aiming to raise capital for its innovative therapeutics targeting serious viral diseases [1][4]. Group 1: Offering Details - The offering consists of 5,591,840 shares of common stock and pre-funded warrants for 1,040,820 shares, with a combined price of $19.60 per share and accompanying warrants [1]. - Each pre-funded warrant has a nominal exercise price of $0.001 and is immediately exercisable, while Class A and Class B warrants have an exercise price of $21.60 and specific expiration conditions [1]. - The offering and a private placement with Gilead Sciences, Inc. are expected to close on August 11, 2025, contingent upon customary closing conditions [4]. Group 2: Investor Participation - The offering includes participation from both new and existing investors, such as Commodore Capital, Blackstone Multi-Asset Investing, and Farallon Capital Management [2]. - Gilead will purchase 2,295,920 shares in a private placement at the same price as the offering, which will not be registered under the Securities Act [3]. Group 3: Use of Proceeds - The net proceeds from the offering and private placement will be utilized for general corporate purposes [4]. Group 4: Company Overview - Assembly Biosciences is focused on developing small-molecule therapeutics aimed at serious viral diseases, including herpesvirus and hepatitis infections [7][8].

Core Viewpoint - Dryden Gold Corp. is increasing its previously announced non-brokered equity financing due to excess demand, aiming to raise up to $7,820,120 through the issuance of common shares [1][3]. Financing Details - The Upsized LIFE Financing will consist of up to 31,721,667 common shares, including: - Up to 9,216,667 flow-through common shares (FT Shares) at $0.24 each, raising up to $2,212,000 - Up to 13,180,000 charity flow-through common shares (CFT Shares) at $0.284 each, raising up to $3,743,120 - Up to 9,325,000 hard dollar common shares (HD Shares) at $0.20 each, raising up to $1,865,000 [1][3]. Use of Proceeds - Proceeds from the financing will be allocated as follows: - Funding additional drilling on the Dryden Gold Property in northwestern Ontario - Working capital and general administrative expenses from HD Shares - Eligible resource exploration expenses from FT Shares and CFT Shares, qualifying as Canadian exploration expenses and flow-through mining expenditures [3][4]. Centerra Gold Participation - Centerra Gold Inc. will exercise its 'top-up right' to maintain a 9.9% interest in Dryden Gold, as per the investor rights agreements dated December 17, 2024 [2]. Closing and Regulatory Approvals - The Upsized LIFE Financing is expected to close on or before August 14, 2025, subject to regulatory approvals, including from the TSX Venture Exchange [4][5]. Company Overview - Dryden Gold Corp. is focused on discovering high-grade gold mineralization and controls a 100% interest in a strategic land position in the Dryden District of Northwestern Ontario, with a strong management team and a history of building shareholder value [7].

Core Viewpoint - Revival Gold Inc. has successfully closed a financing round, raising approximately C$29.08 million through the issuance of common shares, enhancing its balance sheet and supporting its gold asset value for shareholders [1][3]. Financing Details - The financing consisted of a strategic non-brokered private placement with EMR Capital Management Limited, which subscribed for 32,069,531 common shares at C$0.48 per share, totaling gross proceeds of approximately US$11.3 million (C$15.4 million) [2]. - A concurrent non-brokered private placement involved the issuance of 28,517,502 common shares at the same price, generating gross proceeds of C$13.68 million [2]. - Post-financing, EMR and Dundee Corporation hold approximately 11.8% and 5.3% ownership in Revival Gold, respectively [2]. Strategic Implications - The financing was structured to be favorable to existing shareholders, avoiding debt and not compromising future strategic flexibility [3]. - EMR has been granted the right to nominate one director to the board and has customary anti-dilution rights [4]. Leadership Changes - Tony Manini, a geologist with over 35 years of experience, has been appointed as a director following EMR's investment, while former director Norm Pitcher transitions to a senior advisory role [5][6][7]. Use of Proceeds - The net proceeds from the offerings will be allocated to advancing the exploration and development of the Mercur and Beartrack-Arnett projects, as well as for general working capital and corporate purposes [9]. Regulatory Compliance - The common shares issued under the concurrent offering are exempt from hold periods under applicable Canadian securities laws, while those from the EMR placement are subject to a 4-month and one-day hold period [8][9].

Core Viewpoint - LOBO EV Technologies Ltd. is in advanced negotiations with Strattners for a potential equity financing facility, which could provide up to $10 million in capital over three years, supporting the company's long-term growth and expansion plans [1][2][5]. Group 1: Equity Financing Details - Strattners aims to become a cornerstone investor in LOBO, expressing optimism about the company's long-term development potential [2]. - The agreement allows LOBO to issue and sell ordinary shares to Strattners at its discretion, without a volume-weighted average price mechanism [3]. - The proceeds from any share issuance will be used for general corporate purposes, including working capital, capital expenditures, product development, and expansion initiatives [4]. Group 2: Company Overview - LOBO EV Technologies Ltd. specializes in the design, development, manufacturing, and sale of e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles [6]. - The company is also expanding into AI-powered multimedia interactive systems and medical technology manufacturing, aiming to provide intelligent and efficient mobility and healthcare solutions [6].

Core Viewpoint - Dryden Gold Corp. is proposing a non-brokered equity financing to raise up to $7 million through the issuance of various types of shares, aimed at expanding its drill program and for general corporate purposes [1][2]. Financing Details - The financing will consist of up to 34,285,714 shares, including: - Up to 14,285,714 flow-through common shares (FT Shares) at $0.24 each, raising a maximum of $2 million - Up to 12,500,000 charity flow-through shares (CFT Shares) at $0.284 each, raising a maximum of $3.55 million - Up to 7,500,000 hard dollar shares (HD Shares) at $0.20 each, raising a maximum of $1.45 million [1][2]. - The offering is subject to regulatory approvals and will close in one or more tranches by September 5, 2025 [3]. Use of Proceeds - Proceeds from the financing will be allocated to expand the current drill program to 30,000 meters and for general corporate purposes [2]. Tax Implications - The FT Shares and CFT Shares will qualify as "flow-through shares" under Canadian tax law, with proceeds used for eligible resource exploration expenses [4]. Insider Participation - The company anticipates that insiders may subscribe for HD Shares, which will be treated as a related party transaction [5]. Company Overview - Dryden Gold Corp. is focused on discovering high-grade gold mineralization and controls a 100% interest in a strategic land position in the Dryden District of Northwestern Ontario, with a property that includes historic gold mines and significant exploration potential [6].

Company Announcement - Great Pacific Gold Corp. has appointed Alex Heath as Chief Financial Officer, effective immediately, while the current CFO Jonathan Richards will assist for the next two months to ensure a smooth transition [1][2][3] Executive Background - Alex Heath brings over twenty years of experience in finance, investment banking, corporate development, and investor relations, having held senior roles in various companies, including Defense Metals Corp. and Prospector Metals Corp. [2] Financial Position - The company successfully closed an equity financing raising $16.9 million, which positions it well to advance its drilling program at the Wild Dog Project in Papua New Guinea [3] Stock Options and RSUs - In conjunction with the CFO appointment, the company issued 500,000 stock options and 250,000 restricted share units (RSUs), with specific vesting schedules for both [3] Project Overview - Great Pacific Gold has a portfolio of exploration-stage projects in Papua New Guinea, focusing on developing gold-copper resources [4] - The Wild Dog Project is a brownfield exploration project with a history of small-scale gold mining and is currently undergoing a drilling program [4] - The Kesar Project is a greenfield exploration project with high-priority targets and has shown high grades of gold in previous exploration [4] - The Arau Project contains the Mt. Victor exploration target, which has potential for a high sulphidation epithermal gold-base metal deposit [4][5]